Skip to content

PHATHOM PHARMACEUTICALS, INC.

PHAT

CIK 0001783183

← back to feed
Revenue (TTM)
$175.83M
+216.9% YoY Q1 Apr 2026
Net Income (TTM)
−$230.47M
+33.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.14
+42.7% YoY Q1 Apr 2026
Gross Margin
84.7%
Q1 Apr 2026
Operating Margin
-96.4%
Q1 Apr 2026
Net Margin
-131.1%
Q1 Apr 2026
Free Cash Flow (TTM)
−$209.6M
Q1 Apr 2026
Cash
$180.9M
Q1 Apr 2026
Total Debt
$163.68M
Q1 Apr 2026
Shares Outstanding
79.76M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings